Back to Search
PATRICK KEEGAN, MD
MD
Pediatric Critical Care Medicine Physician
NPI: 1508885401Individual
Specialties, Licenses & Credentials
Pediatric Critical Care Medicine PhysicianPrimary
Pediatrics — Pediatric Critical Care Medicine
Code: 2080P0203X
23738(TN)
Research & Publications (18)
FDA review of a panitumumab (Vectibix) clinical trial for first-line treatment of metastatic colorectal cancer.
PMID 19282350·Oncologist·2009
4-observational
U.S. Food and Drug Administration approval: panitumumab for epidermal growth factor receptor-expressing metastatic colorectal carcinoma with progression following fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens.
PMID 18316547·Clin Cancer Res·2008
4-observational
FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia.
PMID 18305062·Oncologist·2008
4-observational
Continuing reassessment of the risks of erythropoiesis-stimulating agents in patients with cancer.
PMID 18519748·Clin Cancer Res·2008
1-meta
FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer.
PMID 17405901·Oncologist·2007
4-observational
Periurethral injection therapy for urinary incontinence in women.
PMID 17636740·Cochrane Database Syst Rev·2007
1-meta
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).
PMID 17766659·Oncologist·2007
4-observational
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.
PMID 17602060·Oncologist·2007
8-other
The effect of neuronal morphology and membrane-permeant weak acid and base on the dissipation of depolarization-induced pH gradients in snail neurons.
PMID 16341877·Pflugers Arch·2006
7-preclinical
Development and regulation of monoclonal antibody products: challenges and opportunities.
PMID 16408162·Cancer Metastasis Rev·2005
7-preclinical
Accelerated approval of oncology products: a decade of experience.
PMID 15494600·J Natl Cancer Inst·2004
6-review
Early clinical trials of chemopreventive and biologic agents: Designs, populations, and endpoints.
PMID 11295631·Urology·2001
8-other
Re: A prospective pilot evaluation of urinary and immunohistochemical markers as predictors of clinical stage of urothelial carcinoma of the bladder.
PMID 11119116·BJU Int·2000
8-other
The major tegumental antigen of Fasciola hepatica contains repeated elements.
PMID 11085238·Parasitology·2000
7-preclinical
Study design in the evaluation of breast cancer imaging technologies.
PMID 10987329·Acad Radiol·2000
8-other
Statistical problems with 'optimal' thresholds in studies of new prognostic factors in urology.
PMID 10691812·BJU Int·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 910 BLACKFORD ST
CHATTANOOGA, TN 37403 - Phone
- (423) 778-5445
Quick Facts
- NPI
- 1508885401
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 18
Are you this provider?
Claim Your Profile